Total Payments
$24,032
2024 Payments
$6,012
Companies
18
Transactions
153
Payment Breakdown by Category
Travel$10,234 (42.6%)
Other$9,450 (39.3%)
Food & Beverage$4,347 (18.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $10,234 | 20 | 42.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,450 | 7 | 39.3% |
| Food and Beverage | $4,347 | 126 | 18.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $20,639 | 53 | $0 (2024) |
| Fennec Pharmaceuticals, Inc. | $738.41 | 7 | $0 (2024) |
| Genmab U.S., Inc. | $572.21 | 23 | $0 (2024) |
| Coherus Biosciences Inc. | $522.48 | 9 | $0 (2024) |
| Blueprint Medicines Corporation | $464.09 | 13 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $209.32 | 12 | $0 (2024) |
| Napo Pharmaceuticals Inc | $205.67 | 4 | $0 (2024) |
| Tempus AI, Inc | $136.65 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $108.41 | 5 | $0 (2024) |
| Amgen Inc. | $93.80 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,012 | 73 | Merck Sharp & Dohme LLC ($3,629) |
| 2023 | $8,648 | 45 | Merck Sharp & Dohme LLC ($7,998) |
| 2022 | $9,299 | 31 | Merck Sharp & Dohme LLC ($8,939) |
| 2021 | $72.61 | 4 | Merck Sharp & Dohme Corporation ($72.61) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/28/2024 | Fennec Pharmaceuticals, Inc. | Pedmark (Drug) | Food and Beverage | In-kind items and services | $41.07 | General |
| Category: Cisplatin-induced Ototoxicity | ||||||
| 12/27/2024 | Fennec Pharmaceuticals, Inc. | Pedmark (Drug) | Food and Beverage | In-kind items and services | $104.31 | General |
| Category: Cisplatin-induced Ototoxicity | ||||||
| 12/19/2024 | Napo Pharmaceuticals Inc | GELCLAIR CONCENTRATED ORAL GEL (Device) | Food and Beverage | Cash or cash equivalent | $27.24 | General |
| Category: Oncology | ||||||
| 12/19/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Napo Pharmaceuticals Inc | GELCLAIR CONCENTRATED ORAL GEL (Device) | Food and Beverage | Cash or cash equivalent | $130.13 | General |
| Category: Oncology | ||||||
| 12/07/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Coherus Biosciences Inc. | Udenyca (Biological), LOQTORZI | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 12/05/2024 | Coherus Biosciences Inc. | Udenyca (Biological), LOQTORZI | Food and Beverage | In-kind items and services | $4.13 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Napo Pharmaceuticals Inc | GELCLAIR CONCENTRATED ORAL GEL (Device) | Food and Beverage | Cash or cash equivalent | $29.86 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $121.65 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Coherus Biosciences Inc. | LOQTORZI (Biological) | Food and Beverage | In-kind items and services | $108.78 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Coherus Biosciences Inc. | LOQTORZI (Biological), Udenyca | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Napo Pharmaceuticals Inc | GELCLAIR CONCENTRATED ORAL GEL (Device) | Food and Beverage | Cash or cash equivalent | $18.44 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,365.00 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $1,715.65 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $145.53 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $109.05 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Oncology | ||||||
About Leslie Worona, FNP-BC
Leslie Worona, FNP-BC is a Family healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2010. The National Provider Identifier (NPI) number assigned to this provider is 1548576457.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Leslie Worona, FNP-BC has received a total of $24,032 in payments from pharmaceutical and medical device companies, with $6,012 received in 2024. These payments were reported across 153 transactions from 18 companies. The most common payment nature is "Travel and Lodging" ($10,234).
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location New York, NY
- Active Since 08/30/2010
- Last Updated 01/07/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548576457
Products in Payments
- KEYTRUDA (Biological) $20,502
- Pedmark (Drug) $738.41
- Tivdak (Drug) $450.56
- Udenyca (Biological) $393.24
- GAVRETO (Drug) $367.27
- GELCLAIR CONCENTRATED ORAL GEL (Device) $205.67
- LOQTORZI (Biological) $129.24
- Epkinly (Drug) $121.65
- LIBTAYO (Biological) $108.41
- Lenvima (Drug) $93.22
- Fabhalta (Drug) $86.73
- XT CDX (Device) $84.96
- Vitrakvi (Drug) $80.53
- AYVAKIT (Drug) $63.25
- MEKINIST (Drug) $56.63
- LUMAKRAS (Drug) $55.50
- PROMACTA (Drug) $42.78
- Nplate (Biological) $38.30
- Tirosint (Drug) $35.06
- Tavalisse (Drug) $24.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in New York
Miss. Kara Trlica, Aprn, APRN
Family — Payments: $185,699
Family $185,699
Casey Grillo
Family — Payments: $152,351
Family $152,351
Mary Sullivan-Whalen, Fnp, FNP
Family — Payments: $113,037
Family $113,037
Christina Nalbone, Msn, Fnp-C, MSN, FNP-C
Family — Payments: $102,530
Family $102,530
Derek Pineda, Np, NP
Family — Payments: $32,887
Family $32,887
Tara Mccabe, N.p, N.P
Family — Payments: $20,890
Family $20,890